Company profile

Sydney Neuroimaging Analysis Centre Pty Ltd

Sydney Neuroimaging Analysis Centre Pty Ltd has 1 AI-enabled medical device on the FDA list. The first decision was on December 18, 2023 and the most recent on December 18, 2023 (iQ-solutions). Its most common review panel is Radiology (1 device).

1AI devices

2023First decision

2023Latest decision

1Specialties

Timeline

December 18, 2023 · 510(k) K231929iQ-solutions · Radiology · QIH